Interaction	O
of	O
glucocorticoids	O
with	O
macrophages	B-cell_type
.	O

Identification	O
of	O
glucocorticoid	B-protein
receptors	I-protein
in	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
.	O

Glucocorticoid	O
binding	O
was	O
measured	O
in	O
resident	O
and	O
thioglycollate-elicited	B-cell_type
mouse	I-cell_type
peritoneal	I-cell_type
macrophages	I-cell_type
,	O
rabbit	B-cell_type
alveolar	I-cell_type
macrophages	I-cell_type
,	O
and	O
human	B-cell_type
monocytes	I-cell_type
.	O

Two	O
assays	O
of	O
binding	O
were	O
used	O
--	O
an	O
assay	O
with	O
intact	B-cell_type
cells	I-cell_type
in	O
suspension	O
or	O
monolayers	O
,	O
and	O
an	O
assay	O
of	O
cytosol	O
and	O
nuclear	O
forms	O
of	O
glucocorticoid	B-protein
receptors	I-protein
.	O

The	O
mononuclear	B-cell_type
phagocytes	I-cell_type
contained	O
approximately	O
equal	O
to	O
4	O
--	O
10	O
X	O
10	O
(	O
3	O
)	O
high	B-protein
affinity	I-protein
receptor	I-protein
sites	I-protein
per	O
cell	O
,	O
with	O
dissociation	O
constants	O
of	O
approximately	O
equal	O
to	O
2	O
--	O
8	O
nM	O
dexamethasone	O
.	O

The	O
binding	O
to	O
the	O
saturable	B-protein
sites	I-protein
was	O
specific	O
for	O
steroids	O
with	O
glucocorticoid	O
or	O
antiglucocorticoid	O
activity	O
.	O

Cortisol	O
,	O
corticosterone	O
,	O
and	O
progesterone	O
competed	O
with	O
dexamethasone	O
for	O
binding	O
,	O
whereas	O
estradiol	O
,	O
dihydrotestosterone	O
,	O
and	O
11-epicortisol	O
competed	O
very	O
little	O
.	O

Binding	O
of	O
dexamethasone	O
to	O
cytosol	O
and	O
nuclear	O
forms	O
of	O
the	O
receptor	B-protein
complex	I-protein
and	O
temperature-sensitive	O
translocation	O
of	O
cytosol	O
forms	O
to	O
nuclear	O
forms	O
were	O
shown	O
.	O

At	O
37	O
degrees	O
C	O
the	O
predominant	O
form	O
of	O
the	O
hormone-receptor	B-protein
complex	I-protein
was	O
nuclear	O
.	O

These	O
results	O
demonstrate	O
that	O
corticosteroids	O
interact	O
with	O
macrophages	B-cell_type
at	O
physiological	O
concentrations	O
.	O

INTERACTION	NULL
OF	NULL
GLUCOCORTICOIDS	NULL
WITH	NULL
MACROPHAGES	NULL
Identification	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Monocytes	NULL
and	NULL
Macrophages*	NULL
By	NULL
ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
anp	NULL
ALLAN	NULL
MUNCK	NULL
(	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Radiobiology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143	NULL
,	NULL
and	NULL
the	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Physiology	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
New	NULL
Hampshire	NULL
03755	NULL
)	NULL
The	NULL
mononuclear	NULL
phagocyte	NULL
system	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
mediating	NULL
host	NULL
responses	NULL
in	NULL
inflammation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Glucocorticoids	NULL
have	NULL
anti-inflammatory	NULL
actions	NULL
that	NULL
may	NULL
be	NULL
of	NULL
considerable	NULL
importance	NULL
in	NULL
the	NULL
therapeutic	NULL
effects	NULL
of	NULL
these	NULL
agents	NULL
in	NULL
chronic	NULL
inflammation	NULL
;	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
some	NULL
of	NULL
these	NULL
effects	NULL
are	NULL
mediated	NULL
through	NULL
direct	NULL
hormonal	NULL
action	NULL
on	NULL
macrophages	NULL
.	NULL

Although	NULL
the	NULL
site	NULL
of	NULL
action	NULL
of	NULL
the	NULL
glucocorticoids	NULL
on	NULL
macrophages	NULL
has	NULL
not	NULL
been	NULL
established	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
in	NULL
many	NULL
other	NULL
glucocorticoid	NULL
target	NULL
systems	NULL
the	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
are	NULL
mediated	NULL
by	NULL
specific	NULL
macromolecular	NULL
binding	NULL
proteins	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
receptors	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
established	NULL
that	NULL
monocytes	NULL
and	NULL
macrophages	NULL
contain	NULL
saturable	NULL
glucocorticoid-binding	NULL
proteins	NULL
,	NULL
with	NULL
specificity	NULL
of	NULL
binding	NULL
for	NULL
cortisol	NULL
,	NULL
corticosterone	NULL
,	NULL
and	NULL
related	NULL
synthetic	NULL
steroids	NULL
such	NULL
as	NULL
dexamethasone	NULL
,	NULL
and	NULL
that	NULL
they	NULL
have	NULL
dissociation	NULL
constants	NULL
for	NULL
binding	NULL
within	NULL
physiological	NULL
ranges	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
.	NULL

-	NULL
Mouse	NULL
peritoneal	NULL
macrophages	NULL
were	NULL
harvested	NULL
from	NULL
female	NULL
Swiss	NULL
Webster	NULL
mice	NULL
(	NULL
CD-1	NULL
and	NULL
CF-1	NULL
;	NULL
Charles	NULL
River	NULL
Breeding	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Wilmington	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

weighing	NULL
20-25	NULL
g	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Resident	NULL
macrophages	NULL
were	NULL
obtained	NULL
from	NULL
unstimulated	NULL
animals	NULL
,	NULL
and	NULL
elicited	NULL
macrophages	NULL
were	NULL
obtained	NULL
from	NULL
mice	NULL
injected	NULL
4	NULL
days	NULL
before	NULL
with	NULL
1.0	NULL
ml	NULL
of	NULL
Brewer	NULL
thioglycollate	NULL
medium	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
at	NULL
0.5-1	NULL
x	NULL
10	NULL
``	NULL
cells/well	NULL
in	NULL
2-cm'-diameter	NULL
multiwell	NULL
plates	NULL
(	NULL
Microbiological	NULL
Associates	NULL
,	NULL
Walkersville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
high	NULL
glucose	NULL
formulation	NULL
(	NULL
DME	NULL
)	NULL
'	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
(	NULL
Grand	NULL
Island	NULL
Biological	NULL
Co.	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

.	NULL

1-24	NULL
h	NULL
before	NULL
binding	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
serum-free	NULL
DME	NULL
supplemented	NULL
with	NULL
0.2	NULL
%	NULL
lactalbumin	NULL
hydrolysate	NULL
DME-LH	NULL
.	NULL

Rabbit	NULL
alveolar	NULL
macrophages	NULL
were	NULL
obtained	NULL
by	NULL
lung	NULL
lavage	NULL
10-14	NULL
days	NULL
after	NULL
intravenous	NULL
*	NULL
Supported	NULL
by	NULL
grants	NULL
AM	NULL
14780	NULL
,	NULL
AM	NULL
03535	NULL
,	NULL
and	NULL
CA	NULL
17323	NULL
from	NULL
the	NULL
U.	NULL
S.	NULL
Public	NULL
Health	NULL
Service	NULL
,	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Chapter	NULL
of	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
and	NULL
the	NULL
Dufault	NULL
Bequest	NULL
for	NULL
Arthritis	NULL
Research	NULL
administered	NULL
by	NULL
the	NULL
New	NULL
Hampshire	NULL
Chapter	NULL
of	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
,	NULL
and	NULL
by	NULL
the	NULL
U.	NULL
S.	NULL
Department	NULL
of	NULL
Energy	NULL
.	NULL
'	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
DME	NULL
,	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
;	NULL
DME-LH	NULL
,	NULL
DME	NULL
supplemented	NULL
with	NULL
0.2	NULL
%	NULL
lactalbumin	NULL
hydrolysate	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
K	NULL
,	NULL
,	NULL
half	NULL
maximum	NULL
saturation	NULL
;	NULL
KRPg	NULL
,	NULL
Krebs-Ringer	NULL
phosphate	NULL
buffer	NULL
containing	NULL
5.5	NULL
mM	NULL
glucose	NULL
.	NULL

1684	NULL
J.	NULL
Exp	NULL
.	NULL

Mzo	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
-	NULL
0022-1007/78/0601-1684	NULL
$	NULL
1.00	NULL
ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
AND	NULL
ALLAN	NULL
MUNCK	NULL
1685	NULL
injection	NULL
of	NULL
0.15	NULL
ml	NULL
of	NULL
Freund	NULL
's	NULL
complete	NULL
adjuvant	NULL
(	NULL
Difco	NULL
Laboratories	NULL
,	NULL
Detroit	NULL
,	NULL
Mich.	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
and	NULL
resuspended	NULL
at	NULL
2-4	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
in	NULL
DME-LH	NULL
.	NULL

The	NULL
alveolar	NULL
macrophages	NULL
were	NULL
then	NULL
plated	NULL
in	NULL
multiwell	NULL
dishes	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells/	NULL
well	NULL
,	NULL
or	NULL
cultured	NULL
in	NULL
suspension	NULL
for	NULL
3	NULL
h	NULL
before	NULL
use	NULL
in	NULL
the	NULL
assays	NULL
of	NULL
steroid	NULL
binding	NULL
.	NULL

Cells	NULL
in	NULL
suspension	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
in	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
cytocrits	NULL
of	NULL
0.24-0.36	NULL
for	NULL
binding	NULL
experiments	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
300	NULL
ml	NULL
of	NULL
freshly	NULL
drawn	NULL
,	NULL
citrated	NULL
blood	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
concentrated	NULL
by	NULL
Ficoll-Hypaque	NULL
fractionation	NULL
(	NULL
8	NULL
)	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
(	NULL
Grand	NULL
Island	NULL
Biological	NULL
Co.	NULL
)	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
RPMI-1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
in	NULL
multiwell	NULL
plates	NULL
precoated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
fibrin/	NULL
em	NULL
to	NULL
aid	NULL
adherence	NULL
of	NULL
monocytes	NULL
.	NULL

Nonradioactive	NULL
fibrin	NULL
layers	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
procedure	NULL
used	NULL
for	NULL
``	NULL
I-labeled	NULL
fibrin	NULL
layers	NULL
(	NULL
9	NULL
)	NULL
.	NULL

After	NULL
16	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
CO	NULL
;	NULL
incubator	NULL
,	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
,	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
serum-free	NULL
DME-LH	NULL
for	NULL
2	NULL
h	NULL
before	NULL
measurement	NULL
of	NULL
receptors	NULL
.	NULL

The	NULL
mean	NULL
purity	NULL
of	NULL
the	NULL
monocyte	NULL
preparation	NULL
was	NULL
93	NULL
%	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
in	NULL
a	NULL
Coulter	NULL
counter	NULL
(	NULL
Coulter	NULL
Electronics	NULL
Inc.	NULL
,	NULL
Hialeah	NULL
,	NULL
Fla.	NULL
)	NULL
,	NULL
and	NULL
differential	NULL
cell	NULL
counts	NULL
were	NULL
made	NULL
on	NULL
cytocentrifuge	NULL
preparations	NULL
stained	NULL
with	NULL
Wright	NULL
's	NULL
stain	NULL
.	NULL

Steroid	NULL
Binding	NULL
MEASUREMENT	NULL
OF	NULL
STEROID	NULL
BOUND	NULL
TO	NULL
RECEPTORS	NULL
IN	NULL
INTACT	NULL
CELLS	NULL
.	NULL

-	NULL
Monolayers	NULL
of	NULL
macrophages	NULL
in	NULL
2-em*-diameter	NULL
wells	NULL
were	NULL
washed	NULL
rapidly	NULL
3	NULL
times	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
=2	NULL
ml	NULL
of	NULL
Krebs-Ringer	NULL
phosphate	NULL
buffer	NULL
containing	NULL
5.5	NULL
mM	NULL
glucose	NULL
(	NULL
KRPg	NULL
)	NULL
.	NULL

Each	NULL
well	NULL
then	NULL
received	NULL
100-200	NULL
ul	NULL
of	NULL
KRPg	NULL
containing	NULL
[	NULL
1,2,4-°H	NULL
(	NULL
N	NULL
)	NULL
}	NULL
dexamethasone	NULL
or	NULL
[	NULL
6,7-°H	NULL
(	NULL
N	NULL
)	NULL
]	NULL
dexamethasone	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL

;	NULL
30-50	NULL
Ci/mmol	NULL
)	NULL
.	NULL

In	NULL
a	NULL
few	NULL
experiments	NULL
,	NULL
[	NULL
1,2,3-	NULL
%	NULL
H	NULL
(	NULL
n	NULL
)	NULL
)	NULL
triamcinolone	NULL
acetonide	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
;	NULL
45	NULL
Ci/mmol	NULL
)	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
[	NULL
*H	NULL
]	NULL
)	NULL
dexamethasone	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
70	NULL
min	NULL
,	NULL
then	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

Aliquots	NULL
of	NULL
medium	NULL
from	NULL
each	NULL
well	NULL
were	NULL
taken	NULL
to	NULL
determine	NULL
the	NULL
concentration	NULL
of	NULL
free	NULL
[	NULL
°H	NULL
)	NULL
dexamethasone	NULL
.	NULL

Each	NULL
well	NULL
was	NULL
rinsed	NULL
6	NULL
times	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
ice-cold	NULL
KRPg	NULL
to	NULL
remove	NULL
free	NULL
steroid	NULL
,	NULL
and	NULL
then	NULL
left	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
buffer	NULL
.	NULL

The	NULL
treatment	NULL
at	NULL
room	NULL
temperature	NULL
removed	NULL
most	NULL
of	NULL
the	NULL
nonsaturable	NULL
fraction	NULL
of	NULL
cell-associated	NULL
steroid	NULL
,	NULL
as	NULL
previously	NULL
shown	NULL
for	NULL
thymus	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
steroid	NULL
was	NULL
extracted	NULL
with	NULL
150	NULL
ul	NULL
of	NULL
ethanol	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
50	NULL
Ll	NULL
to	NULL
rinse	NULL
the	NULL
wells	NULL
.	NULL

Samples	NULL
were	NULL
counted	NULL
in	NULL
Bray	NULL
's	NULL
fluid	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
in	NULL
a	NULL
Packard	NULL
Tri-Carb	NULL
liquid	NULL
scintillation	NULL
spectrometer	NULL
(	NULL
Packard	NULL
Instrument	NULL
Co.	NULL
,	NULL
Inc.	NULL
,	NULL
Downers	NULL
Grove	NULL
,	NULL
Ill.	NULL
)	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
by	NULL
conventional	NULL
plots	NULL
of	NULL
bound	NULL
versus	NULL
free	NULL
steroid	NULL
,	NULL
and	NULL
by	NULL
Scatchard	NULL
plots	NULL
separated	NULL
by	NULL
trial	NULL
and	NULL
error	NULL
into	NULL
saturable	NULL
and	NULL
nonsaturable	NULL
components	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Protein	NULL
content	NULL
of	NULL
monolayers	NULL
was	NULL
determined	NULL
in	NULL
sham-treated	NULL
wells	NULL
which	NULL
had	NULL
not	NULL
been	NULL
extracted	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
on	NULL
residual	NULL
cellular	NULL
protein	NULL
after	NULL
ethanol	NULL
extraction	NULL
by	NULL
solubilization	NULL
in	NULL
0.5	NULL
M	NULL
NaOH	NULL
followed	NULL
by	NULL
Lowry-Folin	NULL
procedure	NULL
with	NULL
crystalline	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
standard	NULL
(	NULL
14	NULL
)	NULL
.	NULL

CompEtitivz	NULL
sinping	NULL
stuptEs	NULL
.	NULL

Competition	NULL
for	NULL
binding	NULL
with	NULL
whole	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
for	NULL
binding	NULL
of	NULL
[	NULL
*H	NULL
)	NULL
dexamethasone	NULL
alone	NULL
,	NULL
except	NULL
that	NULL
the	NULL
incubation	NULL
media	NULL
contained	NULL
both	NULL
[	NULL
*H	NULL
)	NULL
dexamethasone	NULL
and	NULL
the	NULL
unlabeled	NULL
competing	NULL
steroid	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
in	NULL
Results	NULL
.	NULL

Cortisol	NULL
and	NULL
other	NULL
steroids	NULL
of	NULL
similar	NULL
solubility	NULL
were	NULL
dissolved	NULL
in	NULL
KRPg	NULL
,	NULL
and	NULL
their	NULL
concentration	NULL
was	NULL
determined	NULL
spectrophotometrically	NULL
by	NULL
measuring	NULL
adsorption	NULL
at	NULL
250	NULL
nm	NULL
and	NULL
assuming	NULL
e	NULL
=	NULL
1.4	NULL
x	NULL
10°	NULL
M~	NULL
'	NULL
em~	NULL
'	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Less	NULL
soluble	NULL
steroids	NULL
such	NULL
as	NULL
estradiol	NULL
were	NULL
dissolved	NULL
in	NULL
ethanol	NULL
;	NULL
incubations	NULL
for	NULL
these	NULL
steroids	NULL
contained	NULL
up	NULL
to	NULL
1	NULL
%	NULL
ethanol	NULL
,	NULL
which	NULL
did	NULL
not	NULL
affect	NULL
dexamethasone	NULL
binding	NULL
.	NULL

Steroids	NULL
were	NULL
obtained	NULL
from	NULL
Steraloids	NULL
,	NULL
Inc.	NULL
,	NULL
Pawling	NULL
,	NULL
N.	NULL
Y.	NULL
,	NULL
Calbi-ochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
,	NULL
or	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL

DEXAMETHASONE	NULL
BINDING	NULL
TO	NULL
``	NULL
CYTOPLASMIC	NULL
``	NULL
AND	NULL
NUCLEAR	NULL
FORMS	NULL
OF	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
AND	NULL
TEMPERATURE-SENSITIVE	NULL
TRANSLOCATION	NULL
FROM	NULL
``	NULL
CYTOPLASMIC	NULL
``	NULL
TO	NULL
NUCLEAR	NULL
FoRMs	NULL
.	NULL

|	NULL
Thioglycollate-elicited	NULL
macrophages	NULL
were	NULL
either	NULL
washed	NULL
out	NULL
of	NULL
the	NULL
peritoneal	NULL
cavity	NULL
of	NULL
mice	NULL
and	NULL
used	NULL
directly	NULL
,	NULL
or	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
100-mm-diameter	NULL
tissue	NULL
culture	NULL
dishes	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
scraped	NULL
off	NULL
the	NULL
surface	NULL
with	NULL
a	NULL
rubber	NULL
policeman	NULL
before	NULL
use	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
sedimented	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
KRPg	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
finally	NULL
incubated	NULL
at	NULL
a	NULL
cytocrit	NULL
of	NULL
0.33	NULL
ml	NULL
packed	NULL
cells/ml	NULL
of	NULL
suspension	NULL
with	NULL
[	NULL
*H	NULL
)	NULL
dexamethasone	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
500	NULL
nM	NULL
unlabeled	NULL
dexamethasone	NULL
.	NULL

The	NULL
values	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
dexamethasone	NULL
were	NULL
for	NULL
nonsaturable	NULL
binding	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
3°C	NULL
for	NULL
120	NULL
min	NULL
,	NULL
then	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
both	NULL
incubations	NULL
,	NULL
the	NULL
cells	NULL
in	NULL
duplicate	NULL
20-ul	NULL
aliquots	NULL
of	NULL
the	NULL
suspensions	NULL
were	NULL
disrupted	NULL
by	NULL
1686	NULL
MACROPHAGE	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
800	NULL
O	NULL
=J	NULL
O	NULL
(	NULL
dpm	NULL
)	NULL
[	NULL
H	NULL
]	NULL
Dexamethasone	NULL
Bound	NULL
p	NULL
o	NULL
6	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
binding	NULL
of	NULL
dexamethasone	NULL
to	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
thioglycollate-elicited	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

Binding	NULL
to	NULL
cells	NULL
was	NULL
with	NULL
2.8	NULL
nM	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
.	NULL

Only	NULL
saturable	NULL
binding	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
nonsaturable	NULL
component	NULL
determined	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
added	NULL
cold	NULL
dexamethasone	NULL
(	NULL
1,000	NULL
nM	NULL
)	NULL
was	NULL
<	NULL
20	NULL
%	NULL
of	NULL
the	NULL
total	NULL
binding	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
3.	NULL
hypotonic	NULL
shock	NULL
in	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
to	NULL
determine	NULL
``	NULL
cytoplasmic	NULL
``	NULL
and	NULL
nuclear	NULL
binding	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
charcoal	NULL
absorption	NULL
and	NULL
nuclear	NULL
pellet	NULL
procedures	NULL
developed	NULL
for	NULL
lymphocytes	NULL
(	NULL
10	NULL
,	NULL
15	NULL
)	NULL
.	NULL

A	NULL
modification	NULL
consisting	NULL
of	NULL
a	NULL
freeze-thaw	NULL
(	NULL
freezing	NULL
in	NULL
acetone-dry	NULL
ice	NULL
,	NULL
thawing	NULL
at	NULL
3°C	NULL
)	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
MgCl	NULL
,	NULL
was	NULL
necessary	NULL
to	NULL
break	NULL
open	NULL
the	NULL
macrophages	NULL
.	NULL

Values	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
for	NULL
saturable	NULL
binding	NULL
,	NULL
obtained	NULL
by	NULL
subtracting	NULL
the	NULL
mean	NULL
for	NULL
nonsaturable	NULL
binding	NULL
at	NULL
4	NULL
nM	NULL
[	NULL
*H	NULL
)	NULL
dexamethasone	NULL
.	NULL

Results	NULL
Physicochemical	NULL
Interactions	NULL
of	NULL
Dexamethasone	NULL
with	NULL
Thioglycollate-Elicited	NULL
Mouse	NULL
Peritoneal	NULL
Macrophages	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
[	NULL
*H	NULL
)	NULL
dexamethasone	NULL
to	NULL
monolayers	NULL
of	NULL
thioglycollate-elicited	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
increased	NULL
rapidly	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
reached	NULL
a	NULL
plateau	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
binding	NULL
at	NULL
3°C	NULL
was	NULL
slower	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Binding	NULL
could	NULL
be	NULL
resolved	NULL
into	NULL
two	NULL
components	NULL
:	NULL
a	NULL
high	NULL
affinity	NULL
component	NULL
,	NULL
which	NULL
was	NULL
saturable	NULL
and	NULL
could	NULL
be	NULL
displaced	NULL
by	NULL
excess	NULL
nonradioactive	NULL
steroid	NULL
,	NULL
and	NULL
a	NULL
low	NULL
affinity	NULL
component	NULL
,	NULL
which	NULL
was	NULL
not	NULL
saturated	NULL
up	NULL
to	NULL
100	NULL
nM	NULL
dexamethasone	NULL
and	NULL
was	NULL
not	NULL
displaced	NULL
by	NULL
excess	NULL
nonradioactive	NULL
steroid	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
high	NULL
affinity	NULL
binding	NULL
had	NULL
a	NULL
half-maximum	NULL
saturation	NULL
(	NULL
K	NULL
,	NULL
)	NULL
at	NULL
3.7	NULL
nM	NULL
dexamethasone	NULL
.	NULL

High	NULL
affinity	NULL
binding	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
the	NULL
prolonged	NULL
washing	NULL
procedures	NULL
used	NULL
,	NULL
whereas	NULL
low	NULL
affinity	NULL
(	NULL
nonsaturable	NULL
)	NULL
binding	NULL
usually	NULL
decreased	NULL
to	NULL
<	NULL
20	NULL
%	NULL
of	NULL
the	NULL
total	NULL
binding	NULL
of	NULL
radioactive	NULL
hormone	NULL
;	NULL
the	NULL
20-min	NULL
room	NULL
temperature	NULL
wash	NULL
was	NULL
particularly	NULL
useful	NULL
in	NULL
decreasing	NULL
nonsaturable	NULL
binding	NULL
.	NULL

High	NULL
affinity	NULL
binding	NULL
was	NULL
=	NULL
80-100	NULL
fmol	NULL
of	NULL
dexamethasone/mg	NULL
cell	NULL
protein	NULL
(	NULL
3,500-6,000	NULL
binding	NULL
sites/cell	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
enhanced	NULL
by	NULL
=20	NULL
%	NULL
when	NULL
the	NULL
macrophages	NULL
were	NULL
removed	NULL
from	NULL
DME	NULL
+	NULL
FCS	NULL
and	NULL
placed	NULL
in	NULL
DME-LH	NULL
at	NULL
least	NULL
1	NULL
h	NULL
before	NULL
experiments	NULL
for	NULL
hormone	NULL
binding	NULL
.	NULL

High	NULL
affinity	NULL
binding	NULL
did	NULL
not	NULL
increase	NULL
further	NULL
with	NULL
culture	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
DME-LH	NULL
for	NULL
up	NULL
to	NULL
72	NULL
h.	NULL
The	NULL
number	NULL
and	NULL
avidity	NULL
of	NULL
the	NULL
hormone	NULL
receptors	NULL
did	NULL
not	NULL
change	NULL
with	NULL
time	NULL
.	NULL

High	NULL
affinity	NULL
binding	NULL
was	NULL
the	NULL
same	NULL
when	NULL
macrophages	NULL
that	NULL
had	NULL
been	NULL
explanted	NULL
1	NULL
,	NULL
24	NULL
,	NULL
72	NULL
,	NULL
or	NULL
144	NULL
h	NULL
were	NULL
used	NULL
.	NULL

Binding	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
number	NULL
of	NULL
macrophages	NULL
adhering	NULL
to	NULL
the	NULL
plate	NULL
.	NULL

Only	NULL
viable	NULL
cells	NULL
bound	NULL
the	NULL
steroid	NULL
;	NULL
macrophages	NULL
killed	NULL
by	NULL
heat	NULL
or	NULL
acid	NULL
did	NULL
not	NULL
bind	NULL
dexamethasone	NULL
.	NULL

ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
AND	NULL
ALLAN	NULL
MUNCK	NULL
1687	NULL
T	NULL
T	NULL
T	NULL
T-	NULL
T	NULL
T	NULL
T	NULL
~T	NULL
T	NULL
jng	NULL
_	NULL
8000	NULL
-mr	NULL
ps3	NULL
<	NULL
.	NULL

e	NULL
B	NULL
c	NULL
i	NULL
A	NULL
~~	NULL
a	NULL
<	NULL
-	NULL
GOOL	NULL
‘	NULL
#	NULL
6000	NULL
-	NULL
T	NULL
8	NULL
‘	NULL
7	NULL
‘	NULL
,	NULL
+	NULL
<	NULL
®	NULL
|	NULL
F	NULL
4	NULL
&	NULL
4000	NULL
7	NULL
_	NULL
w	NULL
2	NULL
4	NULL
bs	NULL
€	NULL
1	NULL
``	NULL
3	NULL
€	NULL
A	NULL
~~	NULL
400	NULL
}	NULL
&	NULL
200	NULL
Eee	NULL
o	NULL
S	NULL
l	NULL
I	NULL
8	NULL
C8	NULL
oa	NULL
a	NULL
4	NULL
a	NULL
a	NULL
a	NULL
olga	NULL
p	NULL
b	NULL
pl	NULL
E	NULL
L	NULL
0	NULL
50	NULL
100	NULL
150	NULL
in	NULL
Free	NULL
Dexamethasone	NULL
(	NULL
n	NULL
M	NULL
)	NULL
5	NULL
5	NULL
200	NULL
”	NULL
C	NULL
a	NULL
~	NULL
-	NULL
o	NULL
LL	NULL
-~	NULL
@	NULL
...	NULL
..	NULL
&	NULL
w	NULL
ane	NULL
azn	NULL
caca	NULL
a	NULL
a	NULL
=s	NULL
»	NULL
2	NULL
gs	NULL
29	NULL
66s	NULL
OO	NULL
ois	NULL
ero	NULL
e	NULL
2	NULL
0	NULL
0	NULL
0	NULL
OL	NULL
8	NULL
O	NULL
1	NULL
1	NULL
1	NULL
_	NULL
|	NULL
__	NULL
__	NULL
1	NULL
|	NULL
da	NULL
0	NULL
5000	NULL
10,000	NULL
Bound	NULL
Dexamethasone	NULL
(	NULL
sites	NULL
per	NULL
cell	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

[	NULL
*H	NULL
]	NULL
dexamethasone	NULL
binding	NULL
of	NULL
thioglycollate-elicited	NULL
macrophages	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
dexamethasone	NULL
to	NULL
intact	NULL
cells	NULL
in	NULL
monolayer	NULL
at	NULL
37°C	NULL
was	NULL
made	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
of	NULL
a	NULL
typical	NULL
experiment	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
Scatchard	NULL
plot	NULL
analyzed	NULL
into	NULL
saturable	NULL
(	NULL
--	NULL
)	NULL
and	NULL
nonsaturable	NULL
(	NULL
-	NULL
-	NULL
-	NULL
)	NULL
components	NULL
,	NULL
and	NULL
as	NULL
a	NULL
conventional	NULL
plot	NULL
of	NULL
bound	NULL
vs.	NULL
free	NULL
dexamethasone	NULL
(	NULL
inset	NULL
)	NULL
.	NULL

The	NULL
parameters	NULL
of	NULL
the	NULL
solid	NULL
lines	NULL
are	NULL
:	NULL
slope	NULL
=	NULL
-K	NULL
,	NULL
=	NULL
0.27	NULL
(	NULL
nM	NULL
)	NULL
,	NULL
intercept	NULL
=	NULL
3,500	NULL
sites/cell	NULL
.	NULL

The	NULL
line	NULL
(	NULL
)	NULL
gives	NULL
the	NULL
sum	NULL
of	NULL
the	NULL
two	NULL
components	NULL
.	NULL

Original	NULL
data	NULL
are	NULL
shown	NULL
by	NULL
(	NULL
@	NULL
)	NULL
and	NULL
original	NULL
data	NULL
after	NULL
subtraction	NULL
of	NULL
the	NULL
nonsaturable	NULL
component	NULL
are	NULL
shown	NULL
by	NULL
(	NULL
0	NULL
)	NULL
.	NULL

I	NULL
Characteristics	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Cultured	NULL
Mononuclear	NULL
Phagocytes	NULL
Receptors	NULL
Source	NULL
Species	NULL
[	NULL
'	NULL
H	NULL
}	NULL
Labeled	NULL
ligand	NULL
-	NULL
``	NULL
``	NULL
O	NULL
``	NULL
®8°	NULL
``	NULL
|	NULL
gites/cell	NULL
_	NULL
K.	NULL
cell	NULL
protein	NULL
nM	NULL
Blood	NULL
monocytes	NULL
Human	NULL
Dexamethasone	NULL
470	NULL
9,000	NULL
7.7	NULL
Resident	NULL
peritoneal	NULL
Mouse	NULL
Triamcinolone	NULL
270	NULL
6,100	NULL
2.1	NULL
macrophages	NULL
acetonide	NULL
Exudative	NULL
perito-	NULL
Mouse	NULL
Dexamethasone	NULL
80	NULL
4,300	NULL
3.7	NULL
neal	NULL
macrophages	NULL
P388D1	NULL
cells	NULL
Mouse	NULL
Dexamethasone	NULL
65	NULL
4,200	NULL
4.0	NULL
Induced	NULL
alveolar	NULL
Rabbit	NULL
Triamcinolone	NULL
3,800*	NULL
4,500	NULL
2.6	NULL
macrophages	NULL
acetonide	NULL
Dexamethasone	NULL
85	NULL
4,600	NULL
1.8	NULL
*	NULL
fmol/ml	NULL
packed	NULL
cells	NULL
.	NULL

1688	NULL
MACROPHAGE	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
TaBur	NULL
II	NULL
Competition	NULL
by	NULL
Various	NULL
Steroids	NULL
for	NULL
Binding	NULL
of	NULL
[	NULL
*H/Dexamethasone	NULL
to	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Plated	NULL
Thioglycollate-Elicited	NULL
Mouse	NULL
Macrophages	NULL
.	NULL

.	NULL

.	NULL

*H	NULL
}	NULL
Dexamethasone	NULL
Competing	NULL
steroid	NULL
Concentration	NULL
binding*	NULL
nM	NULL
%	NULL
control	NULL
Dexamethasone	NULL
1,000	NULL
18	NULL
*	NULL
1	NULL
Cortisol	NULL
100	NULL
77	NULL
#	NULL
1	NULL
1,000	NULL
33	NULL
*	NULL
1	NULL
Corticosterone	NULL
100	NULL
84	NULL
+	NULL
6	NULL
1,000	NULL
40	NULL
*	NULL
2	NULL
Cortexolone	NULL
90	NULL
92	NULL
*	NULL
3	NULL
900	NULL
56	NULL
+	NULL
2	NULL
Progesterone	NULL
120	NULL
93	NULL
+3	NULL
1,200	NULL
54	NULL
+3	NULL
Cortisone	NULL
1,000	NULL
81	NULL
+	NULL
2	NULL
11-Epicortisol	NULL
1,000	NULL
105	NULL
Estradiol	NULL
100	NULL
98	NULL
+	NULL
8	NULL
1,000	NULL
96	NULL
+	NULL
10	NULL
Dihydrotestosterone	NULL
100	NULL
101	NULL
+	NULL
15	NULL
1,000	NULL
85	NULL
*	NULL
11	NULL
Testosterone	NULL
85	NULL
85	NULL
+	NULL
10	NULL
850	NULL
78	NULL
+	NULL
3	NULL
*	NULL
Whole	NULL
cell	NULL
binding	NULL
assay	NULL
;	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
range	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
Dexamethasone	NULL
was	NULL
present	NULL
in	NULL
the	NULL
assay	NULL
at	NULL
8	NULL
nM	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
dexamethasone	NULL
to	NULL
the	NULL
thioglycollate-elicited	NULL
macrophages	NULL
was	NULL
specific	NULL
for	NULL
glucocorticoids	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
,	NULL
dexamethasone	NULL
,	NULL
cortisol	NULL
,	NULL
and	NULL
corticosterone	NULL
competed	NULL
for	NULL
receptor-bound	NULL
[	NULL
*H	NULL
]	NULL
dexamethasone	NULL
.	NULL

Progesterone	NULL
and	NULL
cortexolone	NULL
also	NULL
competed	NULL
for	NULL
receptors	NULL
.	NULL

These	NULL
substances	NULL
sometimes	NULL
act	NULL
as	NULL
antiglucocorticoids	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Cortisone	NULL
had	NULL
a	NULL
small	NULL
but	NULL
reproducible	NULL
competing	NULL
effect	NULL
in	NULL
macrophages	NULL
,	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
some	NULL
limited	NULL
metabolic	NULL
conversion	NULL
to	NULL
cortisol	NULL
may	NULL
have	NULL
occurred	NULL
.	NULL

Estradiol	NULL
,	NULL
11-epicortisol	NULL
,	NULL
testosterone	NULL
,	NULL
and	NULL
dihydrotestosterone	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
.	NULL

In	NULL
many	NULL
other	NULL
glucocorticoid-responsive	NULL
systems	NULL
,	NULL
the	NULL
hormone	NULL
effect	NULL
depends	NULL
upon	NULL
glucocorticoid	NULL
binding	NULL
to	NULL
a	NULL
receptor	NULL
protein	NULL
in	NULL
the	NULL
``	NULL
cytoplasm	NULL
``	NULL
followed	NULL
by	NULL
intracellular	NULL
transport	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
a	NULL
modified	NULL
cytosol	NULL
and	NULL
nuclear-pellet	NULL
preparation	NULL
at	NULL
3°C	NULL
,	NULL
the	NULL
receptor-bound	NULL
dexamethasone	NULL
in	NULL
thioglycollate-elicited	NULL
macrophages	NULL
was	NULL
largely	NULL
found	NULL
in	NULL
a	NULL
soluble	NULL
``	NULL
cytoplasmic	NULL
``	NULL
form	NULL
,	NULL
which	NULL
was	NULL
rapidly	NULL
transferred	NULL
to	NULL
a	NULL
nuclear	NULL
form	NULL
when	NULL
the	NULL
temperature	NULL
was	NULL
raised	NULL
to	NULL
37°C	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
support	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
receptor	NULL
system	NULL
for	NULL
dexamethasone	NULL
in	NULL
elicited	NULL
mouse	NULL
macrophages	NULL
.	NULL

Glucocorticoid	NULL
-	NULL
Receptors	NULL
in	NULL
-	NULL
Resident	NULL
-	NULL
Mouse	NULL
Peritoneal	NULL
-	NULL
Macrophages	NULL
.	NULL

Macrophages	NULL
normally	NULL
residing	NULL
in	NULL
the	NULL
peritoneal	NULL
cavity	NULL
of	NULL
mice	NULL
also	NULL
bound	NULL
glucocorticoids	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
for	NULL
triamcinolone	NULL
acetonide	NULL
,	NULL
K	NULL
,	NULL
=	NULL
2.1	NULL
nM	NULL
)	NULL
and	NULL
contained	NULL
=6,000	NULL
sites/cell	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

As	NULL
in	NULL
elicited	NULL
peritoneal	NULL
macrophages	NULL
,	NULL
steroids	NULL
with	NULL
glucocorticoid	NULL
activity	NULL
(	NULL
triamcinolone	NULL
acetonide	NULL
and	NULL
dexamethasone	NULL
)	NULL
and	NULL
progesterone	NULL
competed	NULL
with	NULL
dexamethasone	NULL
for	NULL
binding	NULL
to	NULL
receptors	NULL
(	NULL
Table	NULL
IID	NULL
)	NULL
.	NULL

ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
AND	NULL
ALLAN	NULL
MUNCK	NULL
1689	NULL
Incubation	NULL
at	NULL
:	NULL
%	NULL
3°C	NULL
37°C	NULL
&	NULL
£	NULL
10,000	NULL
7	NULL
w	NULL
1	NULL
/	NULL
J	NULL
§	NULL
[	NULL
77	NULL
]	NULL
/	NULL
J	NULL
€	NULL
5000	NULL
}	NULL
%	NULL
{	NULL
0	NULL
Cytoplasmic	NULL
Nuclear	NULL
Cytoplasmic	NULL
Nuclear	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Dexamethasone	NULL
binding	NULL
to	NULL
``	NULL
cytoplasmic	NULL
``	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
thioglycollate-elicited	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
and	NULL
temperature-sensitive	NULL
translocation	NULL
from	NULL
``	NULL
cytoplasmic	NULL
``	NULL
to	NULL
nuclear	NULL
forms	NULL
.	NULL

Cell	NULL
suspensions	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Saturable	NULL
binding	NULL
sites	NULL
in	NULL
``	NULL
cytoplasmic	NULL
``	NULL
fractions	NULL
and	NULL
nuclear	NULL
pellets	NULL
for	NULL
cells	NULL
incubated	NULL
at	NULL
3°C	NULL
for	NULL
120	NULL
min	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
;	NULL
sites	NULL
for	NULL
cells	NULL
incubated	NULL
at	NULL
3°C	NULL
for	NULL
120	NULL
min	NULL
followed	NULL
by	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
and	NULL
range	NULL
obtained	NULL
for	NULL
binding	NULL
at	NULL
4	NULL
nM	NULL
Mouse	NULL
Macrophages	NULL
from	NULL
Other	NULL
Sources	NULL
.	NULL

-	NULL
High	NULL
affinity	NULL
saturable	NULL
binding	NULL
of	NULL
glucocorticoids	NULL
to	NULL
macrophages	NULL
elicited	NULL
in	NULL
the	NULL
peritoneal	NULL
cavity	NULL
by	NULL
pristane	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
resident	NULL
lung	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
P388D1	NULL
cells	NULL
from	NULL
a	NULL
macrophage-like	NULL
continuous	NULL
line	NULL
``	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
was	NULL
also	NULL
demonstrated	NULL
.	NULL

Rabbit	NULL
Alveolar	NULL
Macrophages	NULL
.	NULL

Pulmonary	NULL
alveolar	NULL
macrophages	NULL
obtained	NULL
from	NULL
rabbits	NULL
2	NULL
wk	NULL
after	NULL
intravenous	NULL
injection	NULL
of	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
bound	NULL
dexamethasone	NULL
and	NULL
triamcinolone	NULL
acetonide	NULL
to	NULL
high	NULL
affinity	NULL
receptor	NULL
sites	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Cells	NULL
adhering	NULL
to	NULL
plastic	NULL
surfaces	NULL
and	NULL
cells	NULL
in	NULL
suspension	NULL
bound	NULL
the	NULL
glucocorticoid	NULL
equally	NULL
well	NULL
.	NULL

The	NULL
number	NULL
and	NULL
affinity	NULL
of	NULL
the	NULL
rabbit	NULL
macrophage	NULL
glucocorticoid	NULL
receptors	NULL
were	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
mouse	NULL
macrophages	NULL
.	NULL

For	NULL
optimal	NULL
binding	NULL
,	NULL
the	NULL
macrophages	NULL
were	NULL
cultured	NULL
in	NULL
serum-free	NULL
DME-LH	NULL
for	NULL
2-24	NULL
h	NULL
after	NULL
removal	NULL
from	NULL
the	NULL
lungs	NULL
.	NULL

Dexamethasone	NULL
bound	NULL
specifically	NULL
to	NULL
receptors	NULL
with	NULL
high	NULL
affinity	NULL
for	NULL
glucocorticoids	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
dexamethasone	NULL
,	NULL
triamcinolone	NULL
acetonide	NULL
,	NULL
and	NULL
hydrocortisone	NULL
competed	NULL
with	NULL
[	NULL
*H	NULL
)	NULL
}	NULL
dexamethasone	NULL
for	NULL
binding	NULL
to	NULL
receptors	NULL
,	NULL
whereas	NULL
cortisone	NULL
,	NULL
estradiol	NULL
,	NULL
and	NULL
dihydrotestosterone	NULL
did	NULL
not	NULL
.	NULL

Human	NULL
Blood	NULL
Monocytes	NULL
.	NULL

The	NULL
rabbit	NULL
and	NULL
the	NULL
mouse	NULL
are	NULL
glucocorticoid-sensitive	NULL
species	NULL
,	NULL
whereas	NULL
man	NULL
is	NULL
relatively	NULL
glucocorticoid	NULL
resistant	NULL
(	NULL
2	NULL
)	NULL
.	NULL

It	NULL
was	NULL
thus	NULL
of	NULL
particular	NULL
interest	NULL
to	NULL
examine	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Blood	NULL
monocytes	NULL
in	NULL
monolayer	NULL
culture	NULL
bound	NULL
dexamethasone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
high	NULL
affinity	NULL
component	NULL
was	NULL
saturated	NULL
by	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
with	NULL
10	NULL
nM	NULL
dexamethasone	NULL
,	NULL
and	NULL
it	NULL
had	NULL
a	NULL
K	NULL
,	NULL
of	NULL
=7	NULL
nM	NULL
.	NULL

The	NULL
low	NULL
affinity	NULL
component	NULL
was	NULL
nonsaturable	NULL
.	NULL

The	NULL
human	NULL
monocytes	NULL
had	NULL
=9,000	NULL
*	NULL
Werb	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
Foley	NULL
,	NULL
and	NULL
A.	NULL
Munck	NULL
.	NULL

1978	NULL
.	NULL

Glucocorticoid	NULL
receptors	NULL
and	NULL
glucocorticoid-sensitive	NULL
secretion	NULL
of	NULL
neutral	NULL
proteinases	NULL
in	NULL
a	NULL
macrophage	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

In	NULL
press	NULL
.	NULL

1690	NULL
MACROPHAGE	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
Taste	NULL
III	NULL
Competition	NULL
by	NULL
Various	NULL
Steroids	NULL
for	NULL
Binding	NULL
of	NULL
[	NULL
*H/Dexamethasone	NULL
to	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Resident	NULL
Mouse	NULL
Peritoneal	NULL
Macrophages	NULL
Competing	NULL
steroid	NULL
Concentration	NULL
[	NULL
3H	NULL
]	NULL
De	NULL
?	NULL

carr.1ethasone	NULL
binding*	NULL
nM	NULL
%	NULL
control	NULL
None	NULL
-	NULL
100	NULL
+	NULL
3	NULL
Triamcinolone	NULL
acetonide	NULL
10	NULL
34	NULL
+	NULL
0	NULL
100	NULL
29	NULL
+	NULL
1	NULL
Dexamethasone	NULL
100	NULL
32	NULL
+	NULL
1	NULL
1,000	NULL
18	NULL
+	NULL
1	NULL
Cortisol	NULL
100	NULL
63	NULL
+	NULL
12	NULL
1,000	NULL
30	NULL
+	NULL
8	NULL
Cortisone	NULL
1,000	NULL
82	NULL
+	NULL
6	NULL
Progesterone	NULL
100	NULL
73x	NULL
6	NULL
1,000	NULL
38	NULL
+	NULL
9	NULL
11-Epicortisol	NULL
1,000	NULL
107	NULL
+	NULL
8	NULL
Dihydrotestosterone	NULL
1,000	NULL
100	NULL
+	NULL
2	NULL
Estradiol	NULL
1,000	NULL
93	NULL
+	NULL
4	NULL
*	NULL
Whole	NULL
cell	NULL
binding	NULL
assay	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
present	NULL
in	NULL
the	NULL
assay	NULL
at	NULL
3	NULL
nM	NULL
;	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicates	NULL
.	NULL

[	NULL
w	NULL
-	NULL
M	NULL
.6	NULL
a	NULL
``	NULL
C	NULL
A	NULL
6	NULL
c	NULL
80.—	NULL
1	NULL
&	NULL
9	NULL
43—9	NULL
60	NULL
;	NULL
-	NULL
l	NULL
[	NULL
L	NULL
5	NULL
£	NULL
€	NULL
5	NULL
6	NULL
U	NULL
Ex	NULL
40	NULL
|-	NULL
é	NULL
&	NULL
&	NULL
3	NULL
pis	NULL
0	NULL
_	NULL
,	NULL
A	NULL
,	NULL
|	NULL
1	NULL
1	NULL
i	NULL
0	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
Competing	NULL
Steroid	NULL
Conc	NULL
(	NULL
nM	NULL
)	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Competition	NULL
by	NULL
various	NULL
steroids	NULL
for	NULL
binding	NULL
to	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
adherent	NULL
rabbit	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Competition	NULL
for	NULL
binding	NULL
of	NULL
[	NULL
*H	NULL
}	NULL
dexamethasone	NULL
at	NULL
10	NULL
nM	NULL
was	NULL
tested	NULL
with	NULL
dexamethasone	NULL
(	NULL
®	NULL
)	NULL
,	NULL
triamcinolone	NULL
acetonide	NULL
(	NULL
O	NULL
)	NULL
,	NULL
cortisol	NULL
(	NULL
0	NULL
)	NULL
,	NULL
cortisone	NULL
(	NULL
A	NULL
)	NULL
,	NULL
estradiol	NULL
(	NULL
V	NULL
)	NULL
,	NULL
and	NULL
dihydrotestosterone	NULL
(	NULL
W	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
3	NULL
.	NULL

Cone	NULL
,	NULL
concentration	NULL
.	NULL

sites/cell	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
well	NULL
within	NULL
the	NULL
range	NULL
for	NULL
rabbits	NULL
and	NULL
mice	NULL
.	NULL

There	NULL
were	NULL
reproducibly	NULL
more	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
blood	NULL
monocytes	NULL
than	NULL
in	NULL
the	NULL
lymphocytes	NULL
isolated	NULL
from	NULL
the	NULL
same	NULL
preparations	NULL
(	NULL
=3,000	NULL
sites/cell	NULL
)	NULL
,	NULL
and	NULL
platelets	NULL
contaminating	NULL
the	NULL
monocyte	NULL
preparations	NULL
contained	NULL
no	NULL
demonstrable	NULL
receptors	NULL
(	NULL
G.	NULL
Crabtree	NULL
,	NULL
K.	NULL
Smith	NULL
,	NULL
and	NULL
A.	NULL
Munck	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Cortisol	NULL
and	NULL
dexamethasone	NULL
competed	NULL
for	NULL
binding	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
to	NULL
the	NULL
monocytes	NULL
,	NULL
whereas	NULL
steroids	NULL
without	NULL
glucocorticoid	NULL
activity	NULL
did	NULL
not	NULL
(	NULL
Table	NULL
IV	NULL
)	NULL
.	NULL

ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
AND	NULL
ALLAN	NULL
MUNCK	NULL
1691	NULL
<	NULL
-T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
E	NULL
‘	NULL
‘	NULL
zz	NULL
‘	NULL
;	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
mr	NULL
--	NULL
--	NULL
--	NULL
-=	NULL
1000	NULL
}	NULL
\	NULL
\	NULL
|	NULL
7	NULL
@	NULL
a	NULL
a	NULL
1	NULL
&	NULL
€	NULL
-	NULL
o	NULL
*	NULL
``	NULL
3	NULL
%	NULL
&	NULL
€	NULL
P	NULL
b	NULL
!	NULL

.	NULL

$	NULL
|	NULL
7	NULL
u	NULL
%	NULL
£	NULL
``	NULL
[	NULL
*	NULL
bi	NULL
F	NULL
°	NULL
%	NULL
§0	NULL
}	NULL
6	NULL
ae	NULL
l	NULL
n	NULL
p	NULL
5	NULL
*	NULL
e	NULL
__2	NULL
|	NULL
8	NULL
a	NULL
TZ~	NULL
2	NULL
600	NULL
o	NULL
L	NULL
$	NULL
»	NULL
...	NULL
T	NULL
fud	NULL
3	NULL
DL	NULL
p	NULL
g	NULL
a	NULL
a	NULL
a	NULL
a	NULL
g	NULL
ua	NULL
goal	NULL
ap	NULL
a_i	NULL
.	NULL

S	NULL
\	NULL
8	NULL
%	NULL
Or	NULL
ao	NULL
-	NULL
w	NULL
-	NULL
(	NULL
00	NULL
~-	NULL
300	NULL
g	NULL
L	NULL
Free	NULL
Dexamethasone	NULL
{	NULL
(	NULL
n	NULL
M	NULL
)	NULL
7	NULL
pn	NULL
E	NULL
g	NULL
400r—	NULL
«	NULL
.	NULL

@	NULL
i	NULL
o	NULL
a	NULL
.	NULL

a	NULL
@	NULL
U	NULL
P3	NULL
Lat	NULL
)	NULL
fa	NULL
¥	NULL
TTT	NULL
WRs	NULL
,	NULL
@	NULL
revse	NULL
vere	NULL
srs	NULL
serv	NULL
ve	NULL
.	NULL

.	NULL

‘	NULL
~	NULL
w	NULL
°	NULL
Oto	NULL
E	NULL
0	NULL
8	NULL
o	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
.	NULL

1	NULL
|	NULL
1	NULL
1	NULL
c	NULL
0	NULL
25,000	NULL
50,000	NULL
Bound	NULL
Dexamethasone	NULL
{	NULL
sites	NULL
per	NULL
cell	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

[	NULL
*H	NULL
}	NULL
dexamethasone	NULL
binding	NULL
to	NULL
monolayers	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Scatchard	NULL
and	NULL
conventional	NULL
(	NULL
inset	NULL
)	NULL
plots	NULL
of	NULL
bound	NULL
vs.	NULL
free	NULL
dexamethasone	NULL
are	NULL
used	NULL
to	NULL
determine	NULL
saturable	NULL
and	NULL
nonsaturable	NULL
components	NULL
.	NULL

For	NULL
details	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
parameters	NULL
are	NULL
:	NULL
slope	NULL
=	NULL
-K	NULL
,	NULL
=	NULL
0.13	NULL
(	NULL
nM	NULL
)	NULL
,	NULL
intercept	NULL
=	NULL
9,000	NULL
sites/cell	NULL
.	NULL

TaBis	NULL
IV	NULL
Competition	NULL
by	NULL
Various	NULL
Steroids	NULL
for	NULL
Binding	NULL
of	NULL
[	NULL
®*H	NULL
]	NULL
Dexamethasone	NULL
to	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Human	NULL
Monocytes	NULL
.	NULL

.	NULL

.	NULL

{	NULL
°H	NULL
]	NULL
Dexamethasone	NULL
Competing	NULL
steroid	NULL
Concentration	NULL
binding*	NULL
nM	NULL
%	NULL
control	NULL
Dexamethasone	NULL
1,000	NULL
22	NULL
+	NULL
3	NULL
Cortisol	NULL
1,000	NULL
59	NULL
+	NULL
3	NULL
Cortisone	NULL
1,000	NULL
95	NULL
+	NULL
3	NULL
11-Epicortisol	NULL
1,000	NULL
118	NULL
+	NULL
9	NULL
*	NULL
Whole	NULL
cell	NULL
binding	NULL
assay	NULL
;	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

was	NULL
present	NULL
in	NULL
the	NULL
assay	NULL
at	NULL
8	NULL
nM	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
monocyte	NULL
contained	NULL
specific	NULL
binding	NULL
sites	NULL
consistent	NULL
with	NULL
glucocorticoid	NULL
action	NULL
at	NULL
physiological	NULL
concentrations	NULL
.	NULL

Discussion	NULL
The	NULL
studies	NULL
reported	NULL
here	NULL
show	NULL
that	NULL
glucocorticoid	NULL
receptors	NULL
are	NULL
present	NULL
in	NULL
intact	NULL
mononuclear	NULL
phagocytes	NULL
from	NULL
mouse	NULL
,	NULL
rabbit	NULL
,	NULL
and	NULL
man	NULL
.	NULL

The	NULL
dissociation	NULL
constants	NULL
found	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
were	NULL
=2-8	NULL
nM	NULL
for	NULL
dexamethasone	NULL
;	NULL
the	NULL
competition	NULL
for	NULL
binding	NULL
by	NULL
cortisol	NULL
at	NULL
about	NULL
10-fold	NULL
higher	NULL
concentrations	NULL
suggests	NULL
that	NULL
1692	NULL
MACROPHAGE	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
glucocorticoid	NULL
receptor-mediated	NULL
functions	NULL
in	NULL
macrophages	NULL
would	NULL
be	NULL
operative	NULL
at	NULL
physiological	NULL
concentrations	NULL
.	NULL

The	NULL
number	NULL
of	NULL
receptor	NULL
sites	NULL
and	NULL
their	NULL
affinity	NULL
were	NULL
similar	NULL
for	NULL
resident	NULL
macrophages	NULL
,	NULL
macrophages	NULL
elicited	NULL
by	NULL
inflammatory	NULL
stimuli	NULL
,	NULL
and	NULL
blood	NULL
monocytes	NULL
,	NULL
and	NULL
they	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
reported	NULL
for	NULL
lymphoid	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
unstimulated	NULL
monocytes	NULL
and	NULL
macrophages	NULL
had	NULL
higher	NULL
concentrations	NULL
of	NULL
steroid	NULL
receptors	NULL
than	NULL
did	NULL
elicited	NULL
macrophages	NULL
,	NULL
this	NULL
does	NULL
not	NULL
necessarily	NULL
signify	NULL
a	NULL
difference	NULL
in	NULL
sensitivity	NULL
to	NULL
glucocorticoid	NULL
action	NULL
.	NULL

Mitogen-stimulated	NULL
lymphocytes	NULL
contain	NULL
several	NULL
times	NULL
more	NULL
receptors	NULL
than	NULL
unstimulated	NULL
lympho-cytes	NULL
,	NULL
and	NULL
yet	NULL
both	NULL
populations	NULL
are	NULL
equally	NULL
steroid	NULL
sensitive	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
glucocorticoid	NULL
binding	NULL
was	NULL
examined	NULL
with	NULL
dexamethasone	NULL
and	NULL
triamcinolone	NULL
acetonide	NULL
as	NULL
the	NULL
ligands	NULL
.	NULL

These	NULL
synthetic	NULL
glucocorticoids	NULL
have	NULL
the	NULL
advantage	NULL
of	NULL
not	NULL
binding	NULL
to	NULL
transcortin	NULL
,	NULL
a	NULL
serum	NULL
protein	NULL
that	NULL
binds	NULL
cortisol	NULL
(	NULL
17	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
accurate	NULL
glucocorticoid	NULL
concentrations	NULL
could	NULL
be	NULL
determined	NULL
.	NULL

Also	NULL
,	NULL
experiments	NULL
were	NULL
made	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
to	NULL
decrease	NULL
interference	NULL
from	NULL
exogenous	NULL
steroids	NULL
.	NULL

Serum	NULL
cortisol	NULL
and	NULL
progesterone	NULL
both	NULL
compete	NULL
with	NULL
dexamethasone	NULL
for	NULL
binding	NULL
,	NULL
and	NULL
could	NULL
influence	NULL
the	NULL
free	NULL
steroid	NULL
concentrations	NULL
present	NULL
in	NULL
the	NULL
experiments	NULL
.	NULL

In	NULL
other	NULL
work	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
P388D1	NULL
macrophages	NULL
,	NULL
a	NULL
continuous	NULL
cell	NULL
line	NULL
,	NULL
contain	NULL
glucocorticoid	NULL
receptors	NULL
indistinguishable	NULL
from	NULL
those	NULL
of	NULL
normal	NULL
mouse	NULL
macrophages	NULL
.	NULL
``	NULL

We	NULL
have	NULL
demonstrated	NULL
temperature-sensitive	NULL
transfer	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
to	NULL
macrophage	NULL
nuclei	NULL
.	NULL

With	NULL
P388D1	NULL
cells	NULL
we	NULL
have	NULL
been	NULL
able	NULL
to	NULL
demonstrate	NULL
glucocorticoid	NULL
binding	NULL
directly	NULL
to	NULL
proteins	NULL
isolated	NULL
from	NULL
cytoplasm	NULL
,	NULL
temperature-dependent	NULL
activation	NULL
of	NULL
the	NULL
hormone-receptor	NULL
complex	NULL
,	NULL
and	NULL
translocation	NULL
of	NULL
only	NULL
activated	NULL
complexes	NULL
into	NULL
isolated	NULL
nuclei	NULL
.	NULL
``	NULL

In	NULL
virtually	NULL
every	NULL
target	NULL
tissue	NULL
investigated	NULL
,	NULL
the	NULL
first	NULL
step	NULL
in	NULL
steroid	NULL
hormone	NULL
action	NULL
is	NULL
the	NULL
binding	NULL
of	NULL
steroid	NULL
to	NULL
specific	NULL
receptor	NULL
proteins	NULL
.	NULL

Because	NULL
their	NULL
specificity	NULL
and	NULL
affinity	NULL
correlate	NULL
with	NULL
biological	NULL
functions	NULL
,	NULL
they	NULL
may	NULL
mediate	NULL
the	NULL
hormone	NULL
action	NULL
.	NULL

Some	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
on	NULL
macrophages	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
;	NULL
in	NULL
most	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
pharmacological	NULL
concentrations	NULL
of	NULL
steroids	NULL
were	NULL
used	NULL
(	NULL
2	NULL
,	NULL
18	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
high	NULL
affinity	NULL
receptors	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

In	NULL
the	NULL
accompanying	NULL
paper	NULL
(	NULL
18	NULL
)	NULL
hormone	NULL
effects	NULL
at	NULL
glucocorticoid	NULL
concentrations	NULL
similar	NULL
in	NULL
specificity	NULL
and	NULL
affinity	NULL
to	NULL
those	NULL
for	NULL
receptor	NULL
characteristics	NULL
are	NULL
shown	NULL
for	NULL
macrophage	NULL
secretion	NULL
and	NULL
growth	NULL
.	NULL

Summary	NULL
Glucocorticoid	NULL
binding	NULL
was	NULL
measured	NULL
in	NULL
resident	NULL
and	NULL
thioglycollate-elicited	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
,	NULL
rabbit	NULL
alveolar	NULL
macrophages	NULL
,	NULL
and	NULL
human	NULL
monocytes	NULL
.	NULL

Two	NULL
assays	NULL
of	NULL
binding	NULL
were	NULL
used	NULL
-an	NULL
assay	NULL
with	NULL
intact	NULL
cells	NULL
in	NULL
suspension	NULL
or	NULL
monolayers	NULL
,	NULL
and	NULL
an	NULL
assay	NULL
of	NULL
cytosol	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
.	NULL

The	NULL
mononuclear	NULL
phagocytes	NULL
contained	NULL
=4-10	NULL
x	NULL
10°	NULL
high	NULL
affinity	NULL
receptor	NULL
sites	NULL
per	NULL
cell	NULL
,	NULL
with	NULL
dissociation	NULL
constants	NULL
of	NULL
=2-8	NULL
nM	NULL
dexamethasone	NULL
.	NULL

The	NULL
binding	NULL
to	NULL
the	NULL
saturable	NULL
sites	NULL
was	NULL
specific	NULL
for	NULL
steroids	NULL
with	NULL
glucocorticoid	NULL
or	NULL
antiglucocorticoid	NULL
activity	NULL
.	NULL

Cortisol	NULL
,	NULL
corticosterone	NULL
,	NULL
and	NULL
progesterone	NULL
competed	NULL
with	NULL
dexamethasone	NULL
for	NULL
binding	NULL
,	NULL
whereas	NULL
estradiol	NULL
,	NULL
dihy-drotestosterone	NULL
,	NULL
and	NULL
11-epicortisol	NULL
competed	NULL
very	NULL
little	NULL
.	NULL

ZENA	NULL
WERB	NULL
,	NULL
ROSEMARY	NULL
FOLEY	NULL
,	NULL
AND	NULL
ALLAN	NULL
MUNCK	NULL
1693	NULL
Binding	NULL
of	NULL
dexamethasone	NULL
to	NULL
cytosol	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
the	NULL
receptor	NULL
complex	NULL
and	NULL
temperature-sensitive	NULL
translocation	NULL
of	NULL
cytosol	NULL
forms	NULL
to	NULL
nuclear	NULL
forms	NULL
were	NULL
shown	NULL
.	NULL

At	NULL
37°C	NULL
the	NULL
predominant	NULL
form	NULL
of	NULL
the	NULL
hormone-receptor	NULL
complex	NULL
was	NULL
nuclear	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
corticosteroids	NULL
interact	NULL
with	NULL
macrophages	NULL
at	NULL
physiological	NULL
concentrations	NULL
.	NULL

We	NULL
thank	NULL
Ms	NULL
.	NULL

I.	NULL
Vander	NULL
Heiden	NULL
and	NULL
Ms.	NULL
Nancy	NULL
Cidlowski	NULL
for	NULL
their	NULL
technical	NULL
assistance	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
initiated	NULL
while	NULL
Z.	NULL
W.	NULL
was	NULL
a	NULL
visiting	NULL
professor	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
Dr.	NULL
E.	NULL
D.	NULL
Harris	NULL
,	NULL
Jr.	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
27	NULL
January	NULL
1978	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

References	NULL
.	NULL

Nelson	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
editor	NULL
.	NULL

1976	NULL
.	NULL

Immunobiology	NULL
of	NULL
the	NULL
Macrophage	NULL
.	NULL

Academic	NULL
Press	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

.	NULL

Claman	NULL
,	NULL
H.	NULL
N.	NULL
1972	NULL
.	NULL

Corticosteroids	NULL
and	NULL
lymphoid	NULL
cells	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

287:388	NULL
.	NULL

Liao	NULL
,	NULL
S.	NULL
1975	NULL
.	NULL

Cellular	NULL
receptors	NULL
and	NULL
mechanisms	NULL
of	NULL
action	NULL
of	NULL
steroid	NULL
hormones	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

41:87.	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Leung	NULL
.	NULL

1977	NULL
.	NULL

Glucocorticoid	NULL
receptors	NULL
and	NULL
mechanisms	NULL
of	NULL
action	NULL
.	NULL

In	NULL
Receptors	NULL
and	NULL
Mechanism	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones	NULL
,	NULL
Part	NULL
II	NULL
.	NULL

J.	NULL
R.	NULL
Pasqualini	NULL
,	NULL
editor	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

311.	NULL
.	NULL

Werb	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
S.	NULL
Gordon	NULL
.	NULL

1975	NULL
.	NULL

Secretion	NULL
of	NULL
a	NULL
specific	NULL
collagenase	NULL
by	NULL
stimulated	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

142:346.	NULL
.	NULL

Colvin	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
H.	NULL
F.	NULL
Dvorak	NULL
.	NULL

1975	NULL
.	NULL

Fibrinogen/fibrin	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
macro	NULL
phages	NULL
:	NULL
detection	NULL
,	NULL
distribution	NULL
,	NULL
binding	NULL
requirements	NULL
,	NULL
and	NULL
possible	NULL
role	NULL
in	NULL
macrophage	NULL
adherence	NULL
phenomena	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

142:1377.	NULL
.	NULL

Myrvik	NULL
,	NULL
Q.	NULL
N.	NULL
,	NULL
E.	NULL
S.	NULL
Leake	NULL
,	NULL
and	NULL
S.	NULL
Oshima	NULL
.	NULL

1962	NULL
.	NULL

A	NULL
study	NULL
of	NULL
macrophages	NULL
and	NULL
epithelioid-like	NULL
cells	NULL
from	NULL
granulomatous	NULL
(	NULL
BCG-induced	NULL
)	NULL
lungs	NULL
of	NULL
rabbits	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

891745.	NULL
.	NULL

Boyum	NULL
,	NULL
A	NULL
.	NULL

1968	NULL
.	NULL

Isolation	NULL
of	NULL
mononuclear	NULL
cells	NULL
and	NULL
granulocytes	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

Suppl	NULL
.	NULL

97:77.	NULL
.	NULL

Gordon	NULL
,	NULL
S.	NULL
,	NULL
Z.	NULL
Werb	NULL
,	NULL
and	NULL
Z	NULL
.	NULL

A.	NULL
Cohn	NULL
.	NULL

1976	NULL
.	NULL

Methods	NULL
for	NULL
detection	NULL
of	NULL
macrophage	NULL
secretory	NULL
enzymes	NULL
.	NULL

In	NULL
In	NULL
Vitro	NULL
Methods	NULL
in	NULL
Cell-Mediated	NULL
and	NULL
Tumor	NULL
Immunity	NULL
.	NULL

B.	NULL
R.	NULL
Bloom	NULL
and	NULL
J.	NULL
R.	NULL
David	NULL
,	NULL
editors	NULL
.	NULL

Academic	NULL
Press	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

341	NULL
.	NULL

Wira	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
Munck	NULL
.	NULL

1974	NULL
.	NULL

Glucocorticoid-receptor	NULL
complexes	NULL
in	NULL
rat	NULL
thymus	NULL
cells	NULL
.	NULL

``	NULL
Cytoplasmic	NULL
``	NULL
-nuclear	NULL
transformations	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

249:5328	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Brinck-Johnsen	NULL
.	NULL

1968	NULL
.	NULL

Specific	NULL
and	NULL
nonspecific	NULL
physicochemical	NULL
interactions	NULL
of	NULL
glucocorticoids	NULL
and	NULL
related	NULL
steroids	NULL
with	NULL
rat	NULL
thymus	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

243:5556	NULL
.	NULL

Rosenthal	NULL
,	NULL
H.	NULL
E.	NULL
1967	NULL
.	NULL

A	NULL
graphic	NULL
method	NULL
of	NULL
determination	NULL
and	NULL
presentation	NULL
of	NULL
binding	NULL
parameters	NULL
in	NULL
a	NULL
complex	NULL
system	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

20:525	NULL
.	NULL

Munck	NULL
,	NULL
A	NULL
.	NULL

1976	NULL
.	NULL

General	NULL
aspects	NULL
of	NULL
steroid	NULL
hormone-receptor	NULL
interactions	NULL
.	NULL

In	NULL
Receptors	NULL
and	NULL
Mechanism	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones	NULL
,	NULL
Part	NULL
I.	NULL
J.	NULL
R.	NULL
Pasqualini	NULL
,	NULL
editor	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

1	NULL
.	NULL

Lowry	NULL
,	NULL
O.	NULL
H.	NULL
,	NULL
N.	NULL
J.	NULL
Rosebrough	NULL
,	NULL
A.	NULL
L.	NULL
Farr	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Randall	NULL
.	NULL

1951	NULL
.	NULL

Protein	NULL
measurement	NULL
with	NULL
the	NULL
Folin	NULL
phenol	NULL
reagent	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

193:265	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
C.	NULL
Wira	NULL
.	NULL

1975	NULL
.	NULL

Methods	NULL
for	NULL
assessing	NULL
hormone-receptor	NULL
kinetics	NULL
with	NULL
cells	NULL
in	NULL
suspension	NULL
:	NULL
receptor-bound	NULL
and	NULL
nonspecifically	NULL
bound	NULL
hormone	NULL
;	NULL
cytoplasmic-nuclear	NULL
translocation	NULL
.	NULL

In	NULL
Methods	NULL
in	NULL
Enzymology	NULL
.	NULL

B.	NULL
W.	NULL
O'Malley	NULL
and	NULL
J.	NULL
G.	NULL
Hardman	NULL
,	NULL
editors	NULL
.	NULL

Academic	NULL
Press	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

36:255	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
S.	NULL
J.	NULL
Kennedy	NULL
,	NULL
and	NULL
A.	NULL
U.	NULL
Munck	NULL
.	NULL

1977	NULL
.	NULL

Glucocorticoid	NULL
1694	NULL
MACROPHAGE	NULL
GLUCOCORTICOID	NULL
RECEPTORS	NULL
17	NULL
.	NULL

18.	NULL
receptors	NULL
and	NULL
glucocorticoid	NULL
sensitivity	NULL
of	NULL
mitogen	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
human	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

267:523	NULL
.	NULL

Lippman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Thompson	NULL
.	NULL

1974	NULL
.	NULL

The	NULL
role	NULL
of	NULL
transcortin	NULL
in	NULL
glucocorticoid	NULL
mediated	NULL
enzyme	NULL
induction	NULL
:	NULL
tyrosine	NULL
aminotransferase	NULL
induction	NULL
in	NULL
hepatoma	NULL
tissue	NULL
culture	NULL
cells	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

5:461	NULL
.	NULL

Werb	NULL
,	NULL
Z	NULL
.	NULL

1978	NULL
.	NULL

Biochemical	NULL
actions	NULL
of	NULL
glucocorticords	NULL
on	NULL
macrophages	NULL
in	NULL
culture	NULL
.	NULL

Specific	NULL
inhibition	NULL
of	NULL
elastase	NULL
,	NULL
collagenase	NULL
,	NULL
and	NULL
plasminogen	NULL
activator	NULL
secretion	NULL
and	NULL
effects	NULL
on	NULL
other	NULL
metabolic	NULL
functions	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

147:1695	NULL
.	NULL

